Exsurgo is made up of passionate multi-disciplinary professionals working together to design and engineer clinically validated medical products that ease suffering and enhance human potential.
Founded In 2015 by Richard Little and Faisal Almesfer, the Exsurgo team believes that the world deserves access to affordable, drug-free, pain relief.
The founding trio are award-winning bioengineering and clinical specialists with experience in the development, validation and commercialisation of medical devices and services.
With a 17-year history in the rehabilitation sector, the Exsurgo team is leading the way in developing engineered products that ease human suffering and enhance human potential.
Exsurgo’s game-changing technologies are poised to reframe the way the world manages health and wellbeing. From pain and depression to stroke recovery, migraine, ADHD, PTSD, spinal injuries and brain injuries – the possibilities of its application are immeasurable.
The Exsurgo Team
EXECUTIVE TEAM
Chief Science Officer
Chief Technology Officer

ROBERT IRVING
Production Manager



John Emson
Chief Financial Officer



Jiva Muthu
Chief Operating Officer



Alex Little
UK Sales


Robert is an award-winning medical device engineer; he was Richard’s cofounder on the Rex project and has a solid background of transforming medical device engineering concepts into volume manufactured products. Robert’s production engineering background includes medical device quality and regulatory certification and compliance of production facilities.
John has spent over 30 years in finance and M&A across the technology, manufacturing, health and education sectors. In his CFO role, Emson’s focus will be on ensuring Exsurgo has the operational and financial systems to handle its anticipated rapid growth, including compliance with regulatory obligations in a range of key overseas target markets. Emson has an MBA from the University of Birmingham and moved to New Zealand from the UK in 2015.
Jiva has extensive experience encompassing the complete product lifecycle from product development through to manufacturing and market approvals. He has 18 years experience in the medical devices industry with Fisher & Paykel Healthcare, Rex Bionics and Dynamic Controls (an Invacare subsidiary). He has held roles in engineering, R&D management, marketing, global product management, quality and regulatory management. He has a Bachelor of Engineering and a Master of Engineering Studies in Medical Devices and Technologies from Auckland University.
BOARD OF DIRECTORS
CLINICAL ADVISORS

JON GRAHAM
Clinical Advisor



NICk BIRCH
Clinical Advisor


The Exsurgo Team
EXSURGO TEAM
Chief Executive
Chief Science Officer
EXSURGO TEAM
Chief Technology Officer

ROBERT IRvING
Production Engineering


EXSURGO TEAM

JOHN EMSON
Chief Financial Officer



JIVA MUTHU
Chief Operating Officer


John has spent over 30 years in finance and M&A across the technology, manufacturing, health and education sectors. In his CFO role, Emson’s focus will be on ensuring Exsurgo has the operational and financial systems to handle its anticipated rapid growth, including compliance with regulatory obligations in a range of key overseas target markets. Emson has an MBA from the University of Birmingham and moved to New Zealand from the UK in 2015.
Jiva has extensive experience encompassing the complete product lifecycle from product development through to manufacturing and market approvals. He has 18 years experience in the medical devices industry with Fisher & Paykel Healthcare, Rex Bionics and Dynamic Controls (an Invacare subsidiary). He has held roles in engineering, R&D management, marketing, global product management, quality and regulatory management. He has a Bachelor of Engineering and a Master of Engineering Studies in Medical Devices and Technologies from Auckland University.
BOARD OF DIRECTORS

RICHARD LITTLE
Executive Director



yALMAN A kHAN
Independent Director


BOARD OF DIRECTORS

DAvID ROSS
Chairman


ADvISORy BOARD

JON GRAHAM
Clinical Advisor



NICk BIRCH
Clinical Advisor


Keep up to date with the latest Exsurgo progress